日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-Reported Outcomes among people living with Chronic Pruritus (PROs-CP): Protocol for a single-center, multistage, mixed-methods prospective cohort study in Thailand

慢性瘙痒患者报告结局(PROs-CP):泰国单中心、多阶段、混合方法前瞻性队列研究方案

Nochaiwong, Surapon; Ruengorn, Chidchanok; Kiratikanon, Salin; Rujiwetpongstorn, Rujira; Chieosilapatham, Panjit; Tovanabutra, Napatra; Chiewchanvit, Siri; Awiphan, Ratanaporn; Phosuya, Chabaphai; Ruanta, Yongyuth; Thavorn, Kednapa; Chuamanochan, Mati

Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis

二甲双胍治疗黄褐斑的疗效和安全性:系统评价和荟萃分析

Mongkhon, Pajaree; Ruengorn, Chidchanok; Awiphan, Ratanaporn; Phosuya, Chabaphai; Ruanta, Yongyuth; Thavorn, Kednapa; Jamjanya, Sirinda; Chuamanochan, Mati; Nochaiwong, Surapon

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

泰国版简式韧性应对量表的跨文化适应和心理测量学验证:一项在2019冠状病毒病大流行期间于泰国开展的横断面研究

Nochaiwong, Surapon; Ruengorn, Chidchanok; Awiphan, Ratanaporn; Phosuya, Chabaphai; Ruanta, Yongyuth; Kanjanarat, Penkarn; Wongpakaran, Nahathai; Wongpakaran, Tinakon; Thavorn, Kednapa

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

2019冠状病毒病相关公共污名化的差异及相关因素:一项泰国横断面研究

Ruengorn, Chidchanok; Awiphan, Ratanaporn; Phosuya, Chabaphai; Ruanta, Yongyuth; Thavorn, Kednapa; Wongpakaran, Nahathai; Wongpakaran, Tinakon; Nochaiwong, Surapon

COVID-19 Public Stigma Scale (COVID-PSS): development, validation, psychometric analysis and interpretation

新冠肺炎公众污名量表(COVID-PSS):开发、验证、心理测量分析和解释

Nochaiwong, Surapon; Ruengorn, Chidchanok; Awiphan, Ratanaporn; Kanjanarat, Penkarn; Ruanta, Yongyuth; Phosuya, Chabaphai; Boonchieng, Waraporn; Nanta, Sirisak; Chongruksut, Wilaiwan; Thavorn, Kednapa; Wongpakaran, Nahathai; Wongpakaran, Tinakon